Patent · US Active

Methods for enhancing neprilysin activity and degrading amyloid-beta peptides and oligomers in a subject with Alzheimer's disease

US9074238B2 · kind B2 · utility

0Cited by
4References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 8, 2012
Grant dateJul 7, 2015
Priority date
Expiry dateMay 8, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2821
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of enhancing neprilysin activity and/or degrading amyloid-β peptides and/or oligomers in a subject with Alzheimer's disease is disclosed. The method comprises administering to the subject a compound selected from the group consisting ofin a therapeutically effective amount to enhance the neprilysin activity and/or degrade the amyloid-β peptides and oligomers in the subject. Methods of improving symptoms and/or retarding progression of Alzheimer's disease and prophylactic treatment and/or treatment of Alzheimer's disease are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.